phosphodiesterase 2A, CGMP-Stimulated (PDE2A) Peptid
PDE2A
Reaktivität: Säugetier
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN937185
Kurzübersicht für phosphodiesterase 2A, CGMP-Stimulated (PDE2A) Peptid (ABIN937185)
Target
PDE2A
(phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
Spezies
Säugetier
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Protein-Typ
- Synthetic
-
Sequenz
- CRSQQYPAAR PAEPRGQQVF LKPDEPPPQP CADSLQDALL SLGAVIDIAG
-
Produktmerkmale
-
A synthetic peptide for use as a blocking control in assays to test for specificity of Pde2 a antibody,
Alternative Names: Pde2a control peptide, Pde2a antibody Blocking Peptide, Anti-Pde2a Blocking Peptide, phosphodiesterase 2A, cGMP-stimulated Blocking Peptide, Pde2 Blocking Peptide, Pde2a2 Blocking Peptide, Pde2a Blocking Peptide, Pde2a, Pdea-2, Pdea 2, Pdea-2 Blocking Peptide, Pdea 2 Blocking Peptide
-
-
-
-
Applikationshinweise
- Optimal conditions should be determined by the investigator
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C long term.
-
-
- PDE2A (phosphodiesterase 2A, CGMP-Stimulated (PDE2A))
-
Hintergrund
- The activation of Pde2a induces decreased cAMP accumulation, It is involved in nitric oxide mediated signaling in cardiac fibroblasts.
-
Molekulargewicht
- 104 kDa
Target
-
Sie sind hier:
